[go: up one dir, main page]

Naderi‐Meshkin et al., 2015 - Google Patents

Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy

Naderi‐Meshkin et al., 2015

View PDF
Document ID
9161634575768479927
Author
Naderi‐Meshkin H
Bahrami A
Bidkhori H
Mirahmadi M
Ahmadiankia N
Publication year
Publication venue
Cell biology international

External Links

Snippet

Stem/progenitor cell‐based therapeutic approach in clinical practice has been an elusive dream in medical sciences, and improvement of stem cell homing is one of major challenges in cell therapy programs. Stem/progenitor cells have a homing response to injured …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors

Similar Documents

Publication Publication Date Title
Naderi‐Meshkin et al. Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy
Levy et al. Shattering barriers toward clinically meaningful MSC therapies
Ullah et al. Mesenchymal stromal cell homing: mechanisms and strategies for improvement
Kang et al. Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy
Wang et al. Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue
Fu et al. Trophic effects of mesenchymal stem cells in tissue regeneration
Chalisserry et al. Therapeutic potential of dental stem cells
Marquez-Curtis et al. Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF‐1/CXCR4 axis
Murray et al. Natural history of mesenchymal stem cells, from vessel walls to culture vessels
Yin et al. Leveraging stem cell homing for therapeutic regeneration
Segers et al. Biomaterials to enhance stem cell function in the heart
Hocking The role of chemokines in mesenchymal stem cell homing to wounds
Satija et al. Mesenchymal stem cell‐based therapy: a new paradigm in regenerative medicine
Minguell et al. Biology and clinical utilization of mesenchymal progenitor cells
Hwang et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells
Rennert et al. Stem cell recruitment after injury: lessons for regenerative medicine
Karpov et al. Can the outcomes of mesenchymal stem cell‐based therapy for myocardial infarction be improved? Providing weapons and armour to cells
Sarkar et al. Chemical engineering of mesenchymal stem cells to induce a cell rolling response
Faris et al. Therapeutic potential of endothelial colony-forming cells in ischemic disease: strategies to improve their regenerative efficacy
Maijenburg et al. Mesenchymal stromal cell migration: possibilities to improve cellular therapy
Redondo et al. Elements of the niche for adult stem cell expansion
Kholodenko et al. Molecular mechanisms of migration and homing of intravenously transplanted mesenchymal stem cells
Um et al. Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells
Jeong et al. Therapeutic angiogenesis via solar cell-facilitated electrical stimulation
Jiang et al. Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension